Reversible Epigenetic Mechanism at Root of Treatment Resistance in T-ALL | GenomeWeb

NEW YORK (GenomeWeb News) – Treatment resistance in T-cell acute lymphoblastic leukemia can arise through a reversible epigenetic mechanism, researchers led by Bradley Bernstein from Massachusetts General Hospital and Harvard University reported in Nature Genetics yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.